Free Trial

Eurofins Scient (OTCMKTS:ERFSF) Sees Large Volume Increase - Here's What Happened

Eurofins Scient logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Unusually high trading volume: About 13,627 shares traded on Monday, a 146% increase from the prior session's 5,534 shares, with the stock last trading at $69.6275 (previous close $70.95).
  • Mixed analyst views: BNP Paribas Exane upgraded Eurofins to "outperform" while Citigroup remains "neutral"; overall there is one Buy and two Hold ratings, giving an average rating of "Hold."
  • Price below key moving averages: The stock is trading below its 50-day and 200-day moving averages, which are $75.46 and $74.89 respectively, suggesting recent weakness versus longer-term trends.
  • MarketBeat previews top five stocks to own in June.

Eurofins Scient (OTCMKTS:ERFSF - Get Free Report) saw unusually-high trading volume on Monday . Approximately 13,627 shares changed hands during trading, an increase of 146% from the previous session's volume of 5,534 shares.The stock last traded at $69.6275 and had previously closed at $70.95.

Wall Street Analyst Weigh In

A number of equities analysts have commented on the company. BNP Paribas Exane raised Eurofins Scient to an "outperform" rating in a research note on Monday, January 5th. Citigroup reissued a "neutral" rating on shares of Eurofins Scient in a research note on Monday, February 2nd. One investment analyst has rated the stock with a Buy rating and two have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold".

Read Our Latest Stock Report on ERFSF

Eurofins Scient Stock Performance

The stock's fifty day moving average price is $75.46 and its two-hundred day moving average price is $74.89.

About Eurofins Scient

(Get Free Report)

Eurofins Scientific is a global provider of bioanalytical testing and laboratory services, offering a wide array of testing solutions to pharmaceutical, food, environmental, agriscience and consumer products industries. Its core services include pharmaceutical quality control, environmental testing for water and air quality, food safety analysis, agrochemical trials and clinical diagnostic support. The company operates specialized laboratories equipped with advanced analytical technologies such as chromatography, mass spectrometry and molecular biology to ensure compliance with regulatory standards and to support research and development efforts across multiple sectors.

Founded in 1987 by Gilles Martin and headquartered in Luxembourg, Eurofins has grown through a combination of organic expansion and strategic acquisitions.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Eurofins Scient Right Now?

Before you consider Eurofins Scient, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eurofins Scient wasn't on the list.

While Eurofins Scient currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines